fibroblast growth factor (Ajinomoto)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namefibroblast growth factor (Ajinomoto)
Drug Alias NameaFGF (Ajinomoto)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsAlzheimer DiseaseStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAjinomoto Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAjinomoto Co Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseStroke

Other Information

ATC CodeN/A
Related LinksN/A